Matarin Capital Management, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 259 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 3.43 and the average weighting 0.4%.

Quarter-by-quarter ownership
Matarin Capital Management, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$4,584,625,000
-57.8%
33,785
-14.6%
0.37%
-47.0%
Q3 2018$10,856,354,000
+27.2%
39,551
-4.0%
0.70%
+13.5%
Q2 2018$8,535,611,000
+10.7%
41,201
-11.8%
0.62%
+6.7%
Q1 2018$7,713,798,000
+18.2%
46,705
-2.0%
0.58%
+13.8%
Q4 2017$6,526,358,000
+78.7%
47,662
+77.7%
0.51%
+63.9%
Q3 2017$3,652,496,000
+98.3%
26,827
+76.8%
0.31%
+82.4%
Q2 2017$1,842,366,000
-56.3%
15,176
-61.9%
0.17%
-58.9%
Q1 2017$4,211,797,000
-18.6%
39,794
-21.9%
0.41%
-28.9%
Q4 2016$5,174,185,000
-25.0%
50,922
-24.7%
0.58%
-23.5%
Q3 2016$6,901,093,000
-10.4%
67,618
+4.7%
0.76%
-27.3%
Q2 2016$7,705,677,000
+103.2%
64,607
+82.5%
1.05%
+97.5%
Q1 2016$3,792,057,000
+93.1%
35,410
+95.5%
0.53%
+80.3%
Q4 2015$1,963,378,000
+654.6%
18,109
+496.1%
0.29%
+454.7%
Q3 2015$260,205,000
-73.4%
3,038
-80.6%
0.05%
-87.8%
Q2 2014$977,953,000
+33.8%
15,700
+44.5%
0.44%
+0.7%
Q1 2014$730,956,000
+126363.0%
10,866
-1.1%
0.43%
+21.3%
Q4 2013$578,00010,9900.36%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders